USPTO 2015–2025 USPTO PatentsView US Corporation

Achaemenid, LLC

USPTO PatentsView assignee record - 19 granted patents across 13 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Achaemenid ranks #15,081 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 13 technology areas.

#15,081
of 49,997 US assignees by volume
Top 35%
by Innovation Score (40.5/100)
16.3
avg claims per patent
+300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15081 · US Corporation #15,081 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 19 grants
  • MID-PACK #15,081/49,997
  • PHOTO-FINISH AbClonal Science
  • CPC-FOCUS A61F · 13 areas
  • INNOV-PAR 40.5/100
  • CLAIMS-RICH 16.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +300% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: AbClonal Science, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Achaemenid’s 40.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Achaemenid

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Achaemenid's Innovation Score is 40.5/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Achaemenid?

Each dot is one of Achaemenid’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Achaemenid’s own 16.3 claims/patent is at or below the 17.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Achaemenid vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 18.918.91919.1 510152025 Granted patents (volume) Avg claims / patent AVL Test Systems, Inc. - 19, 21AVL Test SystemsAbClonal Science, Inc. - 19, 8.37Abclonal ScienceAbu Dhabi National Oil Company - 19, 15.05Abu Dhabi Nationa…Accelerated Systems Inc. - 19, 18.79Accelerated Syste…Ackley Machine Corporation - 19, 21.53Ackley MachineAclima Inc. - 19, 17.16AclimaAcurx Pharmaceuticals, Inc. - 19, 16.32Acurx Pharmaceuti…Adeia Semiconductor Inc. - 19, 20.11Adeia Semiconduct…Achaemenid, LLC - 19, 16.32Achaemenid
Achaemenid vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Achaemenid's grants concentrate

Achaemenid, LLC is a focused PatentsView assignee: 13 CPC subclasses with 57.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2020. By volume, Achaemenid sits between AVL Test Systems, Inc. and Adeia Semiconductor Inc..

Achaemenid's three-year grant acceleration

Achaemenid, LLC shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Achaemenid's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Achaemenid holds 19 patents at rank #15,109, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Achaemenid

By rank, the assignees closest to #15,109 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Achaemenid's primary technology class.

Achaemenid's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2019202020212022202320242025 4
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Achaemenid, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 3 15.8%
2020 1 5.3%
2021 3 15.8%
2022 3 15.8%
2023 4 21.1%
2024 1 5.3%
2025partial year 4 21.1%

Which technologies does Achaemenid, LLC patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Achaemenid, LLC's patent record in context - here's where to go next.

  • Achaemenid, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 57.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #15,081 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Achaemenid, LLC against AVL Test Systems, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.